Title |
Radiofrequency Ablation of Uterine Fibroids: a Review
|
---|---|
Published in |
Current Obstetrics and Gynecology Reports, November 2016
|
DOI | 10.1007/s13669-016-0183-x |
Pubmed ID | |
Authors |
Bruce B. Lee, Steve P. Yu |
Abstract |
Laparoscopic, ultrasound-guided radiofrequency ablation (RFA) is a new, FDA-cleared uterine sparing, outpatient procedure for uterine fibroids. The procedure utilizes recent technological advancements in instrumentation and imaging, allowing surgeons to treat numerous fibroids of varying size and location in a minimally invasive fashion. Early and mid-term data from multi-center clinical trials have demonstrated safety and efficacy, with resolution or improvement of symptoms and significant volume reduction. Re-intervention rates for fibroid symptoms have been low. The procedure is well tolerated with a typically uneventful and rapid recovery requiring NSAIDs only for postoperative pain. While post RFA pregnancy data are limited, the results are promising. |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 48 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 6 | 13% |
Student > Bachelor | 5 | 10% |
Researcher | 5 | 10% |
Student > Ph. D. Student | 5 | 10% |
Other | 4 | 8% |
Other | 7 | 15% |
Unknown | 16 | 33% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 21 | 44% |
Engineering | 5 | 10% |
Biochemistry, Genetics and Molecular Biology | 3 | 6% |
Nursing and Health Professions | 2 | 4% |
Agricultural and Biological Sciences | 1 | 2% |
Other | 0 | 0% |
Unknown | 16 | 33% |